10x Genomics, Inc. - CL A COM (TXG)

Historical Portfolio Holders from Q3 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / CL A COM
Shares, excl. options Q1 2024
96.8 M
Holdings value Q1 2024
$3.63 B
Value change Q1 2024
+$142 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
271
Number of buys Q1 2024
159
Number of sells Q1 2024
-110
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
88025U109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 96.8 M $3.63 B +$142 M $37.53 271
2023 Q4 91.7 M $5.13 B +$250 M $55.96 265
2023 Q3 89.5 M $3.69 B +$73.6 M $41.25 249
2023 Q2 82.7 M $4.62 B +$183 M $55.84 264
2023 Q1 90.1 M $5.02 B +$210 M $55.79 251
2022 Q4 86.2 M $3.14 B +$102 M $36.44 245
2022 Q3 85.2 M $2.42 B -$45.9 M $28.48 197
2022 Q2 85.9 M $3.9 B +$76.6 M $45.25 219
2022 Q1 81.7 M $6.21 B -$97.6 M $76.07 282
2021 Q4 77.9 M $11.6 B -$1.59 M $148.96 337
2021 Q3 78.8 M $11.5 B +$123 M $145.58 315
2021 Q2 77.5 M $15.2 B +$1.48 B $195.82 334
2021 Q1 68.8 M $12.5 B +$737 M $181.00 309
2020 Q4 66.2 M $9.38 B -$748 M $141.60 294
2020 Q3 68.9 M $8.52 B +$1.08 B $124.68 216
2020 Q2 60.8 M $5.43 B +$1.15 B $89.31 140
2020 Q1 38.9 M $2.42 B +$608 M $62.32 100
2019 Q4 30.8 M $2.35 B +$109 M $76.25 84
2019 Q3 22.3 M $1.13 B +$1.13 B $50.40 92